Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 1 1

Status

Completed 30Terminated 8Recruiting 7Unknown 5Active not recruiting 5Withdrawn 3Suspended 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 2CNS 1

Conditions

Breast Neoplasms 61Stomach Neoplasms 10HER2-positive Breast Cancer 7Colorectal Neoplasms 6Neoplasm Metastasis 5Inflammatory Breast Neoplasms 3Breast Diseases 3Brain Neoplasms 3Pathologic Complete Response 2Neoplasms 2Esophageal Squamous Cell Carcinoma 2Cardiotoxicity 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Relapsed Pediatric Solid Tumor 1Pancreatic Neoplasms 1Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1Invasive Breast Cancer 1Intestinal Neoplasms 1HER2-positive Metastatic Breast Cancer 1HER2-positive Gastric Cancer 1HER2-positive 1HER2+ Early or Locally Advanced Breast Cancer 1HER2+ Breast Cancer 1HER2 Positive Breast Cancer 1HER-2 Positive Gastric Cancer 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Feasibility 1Estrogen Receptor-positive Breast Cancer 1

Interventions

Fluorouracil 19Oxaliplatin 17Capecitabine 16Leucovorin 14Cisplatin 12Irinotecan 11Gemcitabine 11Drug Therapy 11Bevacizumab 10Radiosurgery 9Cetuximab 9pembrolizumab 8Docetaxel 8Everolimus 7spartalizumab 6Sunitinib 6Radiotherapy 6Paclitaxel 6Neoadjuvant Therapy 6Trastuzumab 5S 1 (combination) 5Nivolumab 5Immunotherapy 5Immune Checkpoint Inhibitors 5Cyclophosphamide 5Chemotherapy, Adjuvant 5Carboplatin 5palbociclib 4manganese chloride 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Neoplasm Metastasis × Trastuzumab × Clear all
NCT03588533 2018-07-17

HERZUMA-GC

Dong-A University Hospital

Phase 2 Unknown
50 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01304797 2017-01-06

Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer

Merrimack Pharmaceuticals

Phase 1 Unknown
75 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02238509 2016-06-15

Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies

Consorzio Oncotech

Phase 2 Unknown
154 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00398437 2013-08-12

Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase NA Unknown
96 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

NCT00637325 2008-03-17

TOP

Regione Lombardia

Phase 3 Unknown
500 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡